Tetanus Gamma

Human Tetanus Immunoglobulin (Tetanus Gamma) provides passive immunity against tetanus toxin. Used as post-exposure prophylaxis after injury, it neutralizes circulating toxins. Suitable for those with uncertain or incomplete vaccination history. Short-term protection begins immediately after administration.

Human Tetanus Immunoglobulin is used after potential tetanus exposure to provide immediate, temporary protection. It is commonly administered following wounds or injuries where tetanus risk is present, especially in individuals with incomplete vaccination. The product works by supplying antibodies that neutralize tetanus toxin in the body. It is not a substitute for active immunization but offers rapid, short-term defense.

This medication introduces antibodies that help the body neutralize tetanus toxin. Effects typically begin shortly after administration, with protection lasting several weeks. Most users do not experience immediate noticeable changes, as the product works at a biological level. Mild reactions at the injection site may occur in some individuals.

Store Human Tetanus Immunoglobulin refrigerated between 2°C and 8°C. Do not freeze. Administer only as directed by a healthcare professional. Inform your provider of any allergies, especially to human blood products. Monitor for signs of allergic reactions after administration, such as swelling or difficulty breathing.

No known drug interactions have been established for Human Tetanus Immunoglobulin. However, avoid receiving live vaccines for at least 3 months after administration, as the antibodies may interfere with vaccine effectiveness. Consult a healthcare provider before combining with other injectable medications.